| CEO Name | Rick DeLuca |
| Nationality | United States |
| Net Worth Estimation | $25 million |
Rick DeLuca's estimated net worth of around $25 million stems primarily from his executive compensation as president of MSD Animal Health (Intervet International B.V.), which includes salary, stock awards, performance bonuses, and accumulated equity in Merck & Co. He also benefits from long-term incentive plans and investments tied to Merck's consistent revenue growth and market performance.
Rick DeLuca's estimated net worth of $25,000,000 is 36% of the maximum and 2500% of the minimum CEO net worth in the veterinary business category ($1,000,000-$70,000,000). His net worth is positioned in the upper-mid range compared to peers in this sector.
Business Category: Veterinary
Minimum Net Worth (estimation): 1000000 USD
Maximum Net Worth (estimation): 70000000 USD
Rick DeLuca Performance in MSD Animal Health (Intervet International B.V.)
Rick DeLuca, CEO of MSD Animal Health (Intervet International B.V.), drives strategic leadership focused on innovation in animal health products and global market expansion. His data-driven decision-making emphasizes operational efficiency and sustainable growth, enhancing the company's competitive position. Under his leadership, MSD Animal Health has improved product pipelines and financial performance, solidifying its status as a leader in veterinary pharmaceutical solutions.
Latest News
MSD Animal Health Strengthens Global Animal Health Initiatives and Leadership
MSD Animal Health (formerly Intervet International B.V.) continues to lead in animal health innovation with recent advances in vaccinations for livestock diseases and parasite prevention for dogs, alongside major acquisitions to boost aquaculture sustainability. The company's CEO, Raul Kohan, emphasizes a strategic commitment to veterinarians, producers, and pet owners worldwide, reflecting sustained growth and leadership in the animal health sector.
Source: http://www.msd-animal-health.com